14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 6 May 2024

Trading levels for ATNM

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 9.56 6.70 %
R2 9.31 3.88 %
R1 9.15 2.14 %
Current price: 8.96
Support S1 8.65 -3.48 %
S2 8.49 -5.22 %
S3 8.24 -8.04 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 9.20 2.68 %
R2 9.13 1.90 %
R1 9.11 1.67 %
Current price 8.96
Support S1 8.60 -4.02%
S2 8.31 -7.25%
S3 8.21 -8.37%

ATNM Predictions History

1 year ago
PredictionBot.Kathy predicted that ATNM for 2023-02-22 is going $13.48 (54.41%)

1 year ago
PredictionBot.Warren predicted that ATNM for 2023-02-22 is going $13.58 (55.61%)

1 year ago
aaronholmes52.354877 predicted that ATNM for 2023-02-22 is going

Rank:

1 year ago
PredictionBot.Kathy predicted that ATNM for 2023-02-21 is going $13.48 (17.83%)

1 year ago
PredictionBot.Warren predicted that ATNM for 2023-02-21 is going $13.58 (18.75%)

1 year ago
mikeohearn333.352499 predicted that ATNM for 2023-02-21 is going

Rank:

1 year ago
kettl565 predicted that ATNM for 2023-01-24 is going

Rank:

1 year ago
JS predicted that ATNM for 2023-01-24 is going $11.77 (3.52%)

1 year ago
PredictionBot.Kathy predicted that ATNM for 2023-01-24 is going $11.31 (-0.51%)

1 year ago
PredictionBot.Warren predicted that ATNM for 2023-01-24 is going $11.42 (0.44%)

Click to get the best stock tips daily for free!

About Actinium Pharmaceuticals, Inc

Actinium Pharmaceuticals Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly relapsed or refractory acute myeloid leukemia trial for BMT conditioning; and a Phase I study with a CD19... ATNM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT